Navigation Links
David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
Date:3/17/2009

Joins Two Noted Cardiothoracic Surgeons to Lead Pivotal Trial

ANN ARBOR, Mich., March 17 /PRNewswire/ -- Terumo Heart Inc. today announced that it has appointed David Seth Feldman, MD/PhD, FACC, FAHA to be the Co-Principal Investigator for its Bridge-to-Transplant trial in the United States, studying the new, third generation DuraHeart(TM) Left Ventricular Assist System (LVAS). Dr. Feldman joins Dr. Francis Pagani, Director of the Heart Transplant and Center for Circulatory Support at University of Michigan, and Dr. Yoshifumi Naka, Director of cardiac transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center, in this role.

Dr. Feldman is Director of Heart Failure and Cardiac Transplantation and Director of Heart Failure and Transplant Fellowship Program at The Ohio State University Medical Center. He is Associate Professor of Medicine and Cardiology, with joint faculty positions in physiology and cell biology; Integrated Biological Program and the School of Pharmacy. A renowned heart failure cardiologist, Dr. Feldman holds numerous leadership positions within The Ohio State University, including the Heart Lung Research Institute, Transplant Consortium and Congestive Heart Failure Guidelines Implementation Committee, as well as the National Merit Review Grants-Cardiovascular Section and International Program Committee of the International Society of Heart and Lung Transplantation. Additionally, Dr. Feldman is a reviewer for leading American and European journals and is a molecular biologist with an actively funded NIH Laboratory. He has authored more than 50 peer-reviewed articles and eight book chapters. Dr. Feldman has held leadership roles in 26 clinical trials, as well as presented in numerous national and international medical meetings.

"I am excited to be part of this trial designed to offer new treatment options for patients w
'/>"/>

SOURCE Terumo Heart Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
2. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
3. Cancer Research David Hopes to Slay Cancer Goliath
4. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
5. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
6. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
7. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
8. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
9. /C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/
10. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
11. Fort Worth Surgeon Chosen as Investigator in Clinical Trial for Weight-Loss Device

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...dSTAFA,Switzerland,Nov.25/PRNewswire/-- FromNovemb...earingsolutions,presentedthesecondeditionoftheHear...dsoftheolderpopulation.Theconferencebroughttogethe...ldandmorethan250clinicianswhoworkeverydaywitholder...encesanddiscussthelatestresearchandtrendsinhearing...
(Date:11/25/2009)...ER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradition...on-nucleosidereversetranscriptaseinhibitor(NNRTI)....intreatment-experiencedadultswhoareexperiencingvir...otherantiretroviral(ARV)agents.Thetraditionalappro...DUET-1andDUET-2.INTELENCEiscurrentlymarketedintheU...
(Date:11/25/2009)...RK,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTech...oamthatstopsseverebleeding,wonfirstprizeand$10,000...ecurityChallenge2009,companyofficialsannouncetoday...eworld,Remedium,steampitchedtheirinventionattheGSC...iness. ,, Remedium( www.remediumtechnologies.co...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3First human gets new antibody aimed at hepatitis C virus 9502 1First human gets new antibody aimed at hepatitis C virus 9502 2Climate caused biodiversity booms and busts in ancient plants and mammals 9500 1Climate caused biodiversity booms and busts in ancient plants and mammals 9500 2Sperm Cell Insights May Aid Stem Cell Research 53867 1
(Date:11/27/2009)... Voyant Health™ announced toda...s licensed its TraumaCad Enterprise orthopedic tem... solution. , (PRWEB) Nove...day that Spectrum Health (Grand Rapids, Michigan) ...emplating solution and its TraumaCad Extend workfl...
(Date:11/26/2009)...NCETON,N.J.,Nov.27/PRNewswire/--Thediabetespopulat...earsandannualmedicalspendingonthediseaseisprojecte...toastudypublishedintheDecemberissueof DiabetesCare...,aprogramofNovoNordisk,commissionedtheanalysisbyat...eforecast,thenumberofAmericanslivingwithdiabeteswi...
(Date:11/26/2009)... No more letters from the North Pole...zed text messages from Santa , ...crease operational efficiencies at the North Pole ...eep children all over the globe informed of his Ch...anta’s research department have identified a...
(Date:11/25/2009)...NA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpe...chiropractorcanalsogivepatientsthehelptheyneed.TMJ...ourjaw(mandible)contacts/connectswithyourskull(tem...ithTMJdysfunctionarepainwithchewing,clickingorpopp...dysfunctionincluding:headaches,fatigue,sleepdistur...
(Date:11/25/2009)...GBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmeal...rsinthegreaterLongBeachareathankstoFaithInAction/V...nceatHome(IAH),adivisionofSCANHealthPlan.Formoreth...olunteerstodeliverwarmThanksgivingmealstoseniorsin...LosAngelesandsurroundingcities. ,, "Ourwarmholi...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...better part of three decades, Sherrie Kossoudji ha... chronic pain, tight joints and other types of phy... Rheumatoid arthritis affects my life in as many ... ever really go away. Now 53, Kossoudji i...
...S president Bill Clinton has once again lent a hel...between the Brazil government and drug giant Merc...oundation has helped diffuse the situation. Clinc... drugs and a next generation one-pill-a-day drug. ...
... used diabetes drug dramatically boosted the poten...d together to a variety of cancer cell lines and ...ancer Institute report. Combining a platinum ...given alone, according to the article in the May i...
...excitation through suppressing communication betwe... such as epilepsy and schizophrenia. Rese...pitched upon a protein that could do the trick. Th...he key to tackling diseases such as epilepsy and s...
...perhaps the first clinical study that relates the ...he rescuers, due to inhalation of dust and pollut...m to be suffering a rare type of lung condition wh...d that 13 firefighters and emergency medical servi...
... who took in 100 percent juice, consumed more of f...lt and sugars as compared to those who didnt do a...t but in keeping good health. A new study conducte...th survey conducted from 1999 to 2002 and studying...
Other Medicine News:Health News:Aging Gracefully, With a Chronic Disease 2Health News:Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 3Health News:British Scientists Discover New Protein to Treat Epilepsy and Schizophrenia 2
...chairs with concave seats and large backrests with...backrests, armrests, and casters and glides. &bull...riety of environments including: industry, educati... care and office. • With reinforced nylon bas...
BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q72-CAB-ERB
BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q70-CAB-ERB
...chairs with concave seats and large backrests with...backrests, armrests, and casters and glides. &bull...riety of environments including: industry, educati... care and office. • With cast aluminum base &...
Medicine Products: